Tirzepatide 40mg Injection Pen Kit
The Tirzepatide 40mg Injection Pen Kit from Synedica is a high-purity dual GLP-1 and GIP receptor agonist engineered for advanced laboratory research. Designed for analytical accuracy, this kit pairs a high-concentration dual-action compound with an integrated pre-measured delivery device to support precise experimental workflows.
Technical Specifications of Synedica Tirzepatide 40mg
-
Compound Name: Tirzepatide (Dual GLP-1 / GIP Receptor Agonist)
-
Total Active Concentration: 40mg active research compound per unit
-
Delivery Format: Integrated pre-calibrated injection pen kit system
-
Purity Rating: ≥99.0% (HPLC Verified)
-
Form Factor: Lyophilized formulation housed in an analytical dispensing pen
-
Storage Protocols: Store at -20°C upon receipt; stable at ambient room temperature during domestic transit
Why Choose the Official Synedica Tirzepatide 40mg Pen Kit?
In longitudinal metabolic studies, dual-receptor synergy requires strict batch consistency and exact volume control.
Third-Party Analytical Verification for Synedica Tirzepatide 40mg
Every lot of synedica tirzepatide 40mg undergoes independent High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry testing to guarantee identity, concentration, and freedom from synthesis impurities.
Streamlined Laboratory Handling
By utilizing the integrated pen format, researchers can streamline dosage measuring, reduce manual preparation steps, and minimize volume loss during repeated testing procedures.
Frequently Asked Questions
How is Synedica Tirzepatide 40mg shipped within the UK?
All orders are packaged in protective materials and dispatched domestically from within the UK to ensure temperature stability and physical protection during transport.
Where can I find the COA for my Synedica Tirzepatide 40mg batch?
Every synedica tirzepatide 40mg unit features a lot-specific batch code that links directly to its downloadable third-party Certificate of Analysis (COA) in our online testing repository.
Notice: All Synedica products—including the synedica tirzepatide 40mg pen kit—are sold strictly for in vitro laboratory research, analytical studies, and scientific development. Products are not intended for human or animal consumption, medical treatment, or therapeutic use.